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Summary
Neurotrophin 3 (NT-3) can support the survival of some embryonic sympathetic neuroblasts before
they become nerve growth factor dependent. We show that NT-3 is produced in vivo by nonneuronal
cells neighboring embryonic sympathetic ganglia. NT-3 mRNA is produced by these nonneuronal
cells in vitro and is up-regulated by platelet-derived growth factor, ciliary neurotrophic factor, and
glial growth factor 2 (a neuregulin). Nonneuronal cell–conditioned medium promotes survival and
induces TrkA expression in isolated sympathetic neuroblasts, and this activity is blocked by anti-
NT-3 antibody. Neuroblasts also enhance NT-3 production by nonneuronal cells. Neuroblasts
synthesize several forms of neuregulin, and antibodies to neuregulin attenuate the effect of the
neuroblasts on the nonneuronal cells. These data suggest a reciprocal cell–cell interaction, in which
neuroblast-derived neuregulins promote NT-3 production by neighboring nonneuronal cells, which
in turn promotes neuroblast survival and further differentiation.
Introduction
Growing evidence indicates that neurotrophins act not only as target-derived neuronal survival
factors, but also can regulate mitotic activity and promote differentiation of neuronal progenitor
cells, their survival, or both, in both the PNS (Sieber-Blum, 1991; Kalcheim et al., 1992; Wright
et al., 1992) and CNS (Cattaneo and McKay, 1990; Collazo et al., 1992; Segal et al., 1992;
Ghosh and Greenberg, 1995; Vicario-Abejón et al., 1995). For example, embryonic rat
sympathetic neuroblasts can be supported by neurotrophin 3 (NT-3) before they become nerve
growth factor (NGF) dependent (Birren et al., 1993; Dechant et al., 1993; DiCicco-Bloom et
al., 1993), suggesting that NT-3 may act as an survival factor for these neuronal precursors
(Figure 1A). Similar switches in neurotrophin-responsiveness have been documented for
peripheral sensory neurons as well (Buchman and Davies, 1993; Buj-Bello et al., 1994; Davies,
1994).
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In cultured sympathetic neuroblasts, NT-3 not only supports survival; at higher doses it can
also promote cell cycle arrest, leading to an induction of tyrosine receptor kinase A (TrkA) and
the appearance of NGF responsiveness in embryonic day (E) 14.5 rat sympathetic neuroblasts
(Figure 1B) (Verdi and Anderson, 1994). NT-3 also promotes cell cycle withdrawal in cortical
neuroepithelial precursors (Ghosh and Greenberg, 1995). However, NT-3 is not unique in this
action; ciliary neurotrophic factor (CNTF) has a similar effect on sympathetic neuroblasts as
well (Ernsberger et al., 1989b; Verdi and Anderson, 1994). Indeed, antimitotic agents such as
aphidicolin and mitomycin C induce TrkA even more efficiently than high doses of NT-3 and
CNTF, suggesting that expression of this neurotrophin receptor is primarily a consequence of
mitotic arrest (Figure 1B) (Verdi and Anderson, 1994).
Once TrkA is expressed, NGF in turn is able to upregulate expression of the low affinity NGF
receptor p75 (Figure 1B) (Wyatt and Davies, 1993; Verdi and Anderson, 1994). A likely
consequence of such increased p75 expression is an enhanced sensitivity to NGF (Davies et
al., 1993; Barker and Shooter, 1994; Hantzopoulos et al., 1994; Lee et al., 1994; Verdi et al.,
1994a). NGF can also down-regulate TrkC expression in the neuroblasts (Figure 1B) (Verdi
et al., 1994b) and in this way may contribute to the switch from NT-3 dependence to NGF
dependence. These data illustrate the way in which a relay or cascade of neurotrophins and
neuropoietic cytokines can regulate sequential steps in the survival, early differentiation, and
cell cycle arrest of primary sympathetic neuroblasts in vitro. Similar conclusions have been
drawn from studies of immortalized sympathoadrenal progenitors (Ip et al., 1994).
Targeted inactivation of the NT-3 gene by homologous recombination in mice leads to a 50%
reduction in neuronal number in superior cervical sympathetic ganglia (Ernfors et al., 1994;
Fariñas et al., 1994). By contrast, no such effect on sympathetic development was observed in
mice bearing a null mutation in the CNTF gene (Masu et al., 1993) or in the leukemia inhibitory
factor (LIF) gene (Rao et al., 1993), which encodes a cytokine that interacts with a related
receptor (Davis et al., 1993). In addition, CNTF expression is low or undetectable in early
embryogenesis (Stöckli et al., 1989, 1991). These data provide evidence that NT-3 is important
for the development of at least some sympathetic neurons in vivo, although they do not exclude
a role for a CNTF-related molecule (Leung et al., 1992; Ip et al., 1993). The demonstration
that NT-3 is essential in sympathetic neurogenesis in vivo means that it is important to define
its source and the regulation of its production. Previous work indicated that NT-3 mRNA can
be detected in forming sympathetic ganglia at E14.5 (Schecterson and Bothwell, 1992);
however, these studies did not identify the cell type(s) that produce NT-3.
Here we demonstrate that NT-3 is produced by nonneuronal (nn) cells immediately surrounding
sympathetic ganglia, among which are glial progenitors. In vitro, NT-3 mRNA expression in
these nn cells can be strongly up-regulated by glial growth factor 2 (GGF2, a neuregulin),
platelet-derived growth factor (PDGF), and CNTF. The induction of NT-3 mRNA in these nn
cells is paralleled by an increased secretion of survival-promoting and TrkA-inducing activity
for sympathetic neuroblasts; both such biological activities are inhibited by blocking anti-NT-3
antibodies. Addition of isolated sympathetic neuroblasts to nn cells also up-regulates NT-3
mRNA and enhances secretion of neuroblast survival– promoting activity, which is blocked
by anti-NT-3 antibody. Freshly isolated sympathetic neuroblasts contain various forms of
neuregulin mRNA. The effect of the neuroblasts on nonneuronal cells is attenuated by anti-
GGF/neuregulin antibodies. Taken together, these data suggest that NT-3 is provided to
embryonic sympathetic neuroblasts by surrounding nn cells and that its production in these
cells may in turn be regulated by neuroblast-derived signals including neuregulins. In this way,
a reciprocal cell–cell interaction mediated by neurotrophins and neuregulins may control the
early survival and development of sympathetic neuroblasts.
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Results
NT-3 Is Expressed in nn Cells Surrounding Sympathetic Ganglia
To determine the site of NT-3 expression relative to sympathetic ganglia in vivo, we examined
sections of fetal mice harboring a lacZ gene inserted into the NT-3 locus by homologous
recombination (Fariñas et al., 1994). The expression pattern of β-galactosidase in these mice
reflects the expression of endogenous NT-3 (I. F., unpublished data). Strikingly, β-
galactosidase-positive cells in these mice surrounded but excluded sympathetic ganglia
primordia as revealed by counter-staining with antibody to peripherin (Figure 2A, arrows). The
distribution of the β-galactosidase positive cells at E13.5 overlapped that of cells expressing
p75LNGFR, a marker of peripheral glia and their neural crest progenitors (Stemple and
Anderson, 1992) (Figure 2B, arrow). p75+ nn cells isolated from rat E14.5 sympathetic ganglia
by preparative flow cytometry were labeled by an antibody to NT-3 (see Experimental
Procedures; Figure 3A and 3B). The expression of NT-3 mRNA in these cells was
independently confirmed by reverse transcription–polymerase chain reaction (RT–PCR)
analysis, which also indicated that NT-3 mRNA was undetectable in neuroblasts isolated with
monoclonal antibody B2 (see below; data not shown). Thus, both the antibody staining and
the mRNA analysis confirm that the pattern of β-galactosidase expression seen in sections
likely reflects that of endogenous NT-3 and demonstrates that this neurotrophin is not expressed
by ganglionic neuroblasts at this stage, but rather by surrounding nn cells, at least some of
which are p75+.
Growth Factors Enhance NT-3 mRNA Expression and NT-3-Mediated Bioactivities in
Cultured Nonneuronal Cells
We next examined the regulation of NT-3 production in nn cells isolated from ganglia by
negative selection with monoclonal antibody (MAb) B2 (Birren et al., 1993). The B2− cell
population excludes the sympathetic neuroblasts and contains the p75+ population as well as
other nonneuronal cells (see Experimental Procedures). Because of the larger cell numbers
obtained, it was more convenient to work with B2− cells than p75+ cells as a source of
immunoisolated nn cells. These nonneuronal cells were cultured in an insulin-free, serum-free
defined medium in the presence of various growth factors, including epidermal growth factor
(EGF), insulin-like growth factor (IGF)-1 and IGF-2, fibroblast growth factor (FGF), NGF,
brain-derived neurotrophic factor (BDNF), retinoic acid, and members of the transforming
growth factor-β (TGFβ) superfamily. Of these factors, CNTF, rhGGF2, and PDGF all up-
regulated of NT-3 mRNA by greater than 5-fold after 24 hr (Table 1). No significant effect was
observed with IGF-1, NGF (Table 1), or the other factors tested (data not shown). By 48 hr,
NT-3 mRNA levels were up-regulated over 40-fold (normalized to actin) in rhGGF2- or CNTF-
treated cultures (Table 1). Cell number was also dramatically increased in rhGGF2-treated
cultures (not shown); however, the normalization to actin indicates that there is a significant
induction of NT-3 on a per cell basis, independent of proliferation.
We next asked whether the increase in NT-3 mRNA caused by growth factor treatment was
correlated with an enhanced secretion of functional NT-3, as measured by bioassays using
conditioned medium (CM) from the nn cells. It has been demonstrated previously that
recombinant NT-3 has at least two biological activities on isolated B2+ sympathetic
neuroblasts: at low concentrations (0.3–1.0 ng/ml), it can support their survival; at higher
concentrations (30–50 ng/ml), it can promote mitotic arrest and consequent induction of TrkA
(Verdi and Anderson, 1994). We therefore asked whether these bioactivities were present in
nn cell CM and if so whether they could be inhibited by function-blocking antibodies to NT-3
(design illustrated in Figure 4A and 4B).
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We first assayed survival in cultures of isolated E14.5 B2+ cells. CM from untreated B2− nn
cells enhanced neuroblast survival 2-fold (Table 2, top, no addition, versus Table 2, bottom,
CM [untreated B2− cells]). By 48 hr, the percentage of surviving neurons in the presence of
CM was at least double that seen in controls (Table 2; see Table 5). This survival-enhancing
effect was abolished by adding a function-blocking anti-NT-3 antibody (Ghosh et al.,
1994;Ghosh and Greenberg, 1995) to the CM (compare Table 2, bottom, CM [B2− cells] plus
anti-NT-3 with Table 2, top, no addition). The anti-NT-3 antibody had no effect on neuroblast
survival in basal medium, nor did it reduce neuroblast survival in the presence of insulin (Table
2, top), another survival factor for sympathetic neuroblasts (DiCicco-Bloom and Black,
1988;DiCicco-Bloom et al., 1993;Zackenfels et al., 1995). These biological controls indicated
that the anti-NT-3 antibody does not inhibit neuroblast survival nonspecifically. These data
imply that nn cells constitutively secrete some NT-3, which is able to enhance neuroblast
survival. This conclusion is consistent with the results of the RT–PCR and immunostaining
analyses, in which NT-3 mRNA was clearly detectable in untreated nn cells (Figure 3; see
Table 1).
rhGGF2, CNTF, and PDGF all enhanced the neuroblast survival-promoting activity of B2− nn
cell–CM (prepared from 24 hr cultures) by, on average, ∼50% (Table 2, bottom). Importantly,
these factors had no neuroblast survival–promoting activity on their own (Table 2, top). In
general, rhGGF2 was most effective, consistent with the RT–PCR data indicating that this
growth factor produced the strongest up-regulation of NT-3 mRNA in the nn cells (see Table
1). Importantly, all the survival-enhancing activity of these growth factor–treated CMs could
be blocked by the anti-NT-3 antibody (Table 2, bottom, CM [B2− cells plus GGF] plus anti-
NT-3; data not shown). These data suggest that rhGGF2, PDGF, and CNTF all enhance
neuroblast survival indirectly, by increasing the secretion of NT-3 from nn cells. The apparent
difference between the extent of NT-3 mRNA induction by GGF at 24 hr (about 6-fold; Table
1), and the extent of the increase in survival-promoting activity with GGF-treated CM (50%)
likely reflects the fact that the amount of additional NT-3 in the CM is saturating for the survival
assay, as indicated by the fact that equivalent survival was obtained with this CM as with
saturating amounts of recombinant NT-3 (Table 2). Alternatively, it could reflect
posttranscriptional regulation of NT-3 synthesis or secretion.
In these experiments, we consistently observed a population of neuroblasts that survived
independently of NT-3. In two experiments, this basal NT-3-independent survival was
approximately 50% at 24 hr and 23% at 48 hr (Table 2, top, experiments I and II, no addition;
data not shown). In a third experiment, in which the neuroblast plating density was reduced by
a factor of 3, basal survival was 32% at 24 hr and 15% at 48 hr (Table 2, top, experiment III,
no addition; data not shown). These data are consistent with the observation of a population
of NT-3-independent sympathetic neurons in NT-3 −/− mice (Ernfors et al., 1994;Fariñas et al.,
1994). The size of this NT-3-independent population in the superior cervical ganglion in vivo
is approximately 50% of the total ganglionic neuronal population. These data suggest that in
vitro as in vivo, some embryonic sympathetic neuroblasts do not require NT-3 for survival;
however, the size of the NT-3-independent population may still be affected by environmental
factors or cell–cell interactions.
We next determined whether nn cell CM could induce TrkA expression in isolated neuroblasts.
CM from B2− nn cells pretreated with rhGGF2 or PDGF up-regulated trkA mRNA expression
in isolated B2+ neuroblasts (Figure 5, right; compare GGF, PDGF, with no add). This CM
activity was attenuated by a function-blocking anti-NT-3 antibody (Figure 5, GGF plus NT-3
AB, PDGF plus NT-3 AB). The anti-NT-3 antibody did not affect the TrkA-inducing activity
of CM from cells exposed to CNTF (which has TrkA-inducing activity on its own [Verdi and
Anderson, 1994]); this demonstrates that the antibody does not interfere nonspecifically with
TrkA induction. As in the survival assay, rhGGF2 had no effect on TrkA expression when
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added directly to isolated neuroblasts (Figure 5, left, GGF). These data suggest that rhGGF2
and PDGF promote secretion of sufficient NT-3 from nonneuronal cells to induce trkA
expression in neuroblasts. In contrast, CM from nn cells grown without these growth factors
had little measurable effect on TrkA expression (Figure 5, right, compare no add with no add
plus NT-3 AB). The enhancement of neuroblast survival (Table 2), but not TrkA expression,
by untreated nn cell CM most likely reflects the fact that higher levels of NT-3 are required to
induce TrkA expression than to promote survival (Verdi and Anderson, 1994).
Sympathetic Neuroblasts Contain mRNA for Various Neuregulin Isoforms
The observation that growth factors such as GGF2/neuregulin and PDGF can up-regulate
NT-3 mRNA expression and associated bioactivities in ganglionic nn cells raised the question
of whether sympathetic neuroblasts could be a source of such NT-3-inducing factors. It has
previously been demonstrated that a number of different CNS and PNS neuronal populations,
including embryonic sympathetic neurons, make PDGF (Yeh et al., 1991). Neuregulins have
also been demonstrated to be expressed in the developing nervous system (Marchionni et al.,
1993; Meyer and Birchmeier, 1994; Corfas et al., 1995), but their expression in sympathetic
neuroblasts at these stages has not specifically been examined.
We therefore assayed neuregulin mRNA production in isolated E14.5 B2+ neuroblasts by RT–
PCR. Using exon I-specific primers that identify mRNA encoding GGF2 (the form used in the
cell culture experiments), strong signals were detected in E14.5 and E15.5 B2+ cells, but were
lower in E16.5 and E17.5 cells (Figure 6). To determine whether other neuregulin isoforms
besides GGF2 were expressed in these cells, we performed RT–PCR with several different
primer combinations on mRNA isolated from E14.5 neuroblasts. Signals were detected by use
of primers from the immunoglobulin and EGF domains, as well as from the EGF and
cytoplasmic domains (Table 3). These data, although qualitative, indicate that various forms
of neuregulins including membrane-bound forms are synthesized by embryonic sympathetic
neuroblasts. Importantly, little or no neuregulin mRNA was amplified from E14.5 B2− nn cell
cDNA (data not shown).
Endogenous Neuregulins Enhance Neuroblast Survival in Cocultures with Nonneuronal
Cells
The observations that sympathetic neuroblasts are a potential source of neuregulins, and that
neuregulins enhance NT-3 production in nonneuronal cells, suggested that neuroblast-derived
neuregulins might enhance neuroblast survival in cocultures with nonneuronal cells. To test
this idea, we recombined isolated B2+ neuroblasts together with B2− nonneuronal cells in a
ratio (1:10) reflecting their relative proportions in freshly sorted cell suspensions, and
monitored neuroblast survival. To exclude possible contributions of de novo neurogenesis to
overall neuronal number, cohorts of individual neuroblasts were identified several hours after
plating and their survival followed with time.
Overall neuroblast survival in the cocultures at 24 hr was 77% ± 4.9% (Table 4), much better
than the 45%–50% observed when B2+ neuroblasts are cultured in isolation at the same density
(see above). Inclusion of anti-NT-3 antibodies in the cocultures inhibited survival of a portion
of the neuroblasts (Table 4, anti-NT-3). Importantly, function-blocking antibodies to GGF2/
neuregulin (see Experimental Procedures) also inhibited neuroblast survival (Table 4).
However, at 48 hr, the reduction in survival with anti-GGF was not as great as with anti-NT-3.
This finding is consistent with the observation that nn cells make some NT-3 even in the
absence of sources of GGF/neuregulin (see above).
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These data suggested that endogenous sources of neuregulin can enhance neuroblast survival
in cocultures containing nonneuronal cells. We therefore next asked whether neuroblasts
enhance NT-3 synthesis in nonneuronal cells via neuregulins.
Neuroblasts Up-regulate NT-3 mRNA Expression in Nonneuronal Cells via Neuregulins
B2+ neuroblasts were recombined with B2− nonneuronal cells in a 1:10 ratio, and the expression
of NT-3 mRNA in these cocultures was subsequently measured by RT–PCR. After 48 hr,
NT-3 mRNA levels were 13-fold higher in such cocultures than in sister cultures of nn cells
grown alone (see Table 1, B2+ neuroblasts). To determine whether the NT-3 mRNA produced
in these cocultures was derived from the nn cells, the neuroblasts were removed from the nn
cells by use of EDTA (see Experimental Procedures), and both cell populations were assayed
for NT-3 mRNA by RT–PCR. A strong NT-3 signal was detected in the nn cell cDNA, whereas
no signal was detected in similar amounts of neuroblast cDNA amplified for the same number
of cycles (data not shown). These data are consistent with our finding that NT-3 mRNA is
detectable by RT–PCR in freshly isolated B2− but not B2+ cells from E14.5 ganglia (see above).
Thus, these coculture experiments suggest that B2+ neuroblasts, as well as rhGGF2, PDGF,
and CNTF, can up-regulate NT-3 mRNA production by B2− nn cells.
To determine whether the effect of B2+ neuroblasts in up-regulating NT-3 mRNA production
in nn cells was mediated by endogenous neuregulins, we examined NT-3 mRNA levels in
cocultures grown with or without the function-blocking anti-GGF2/neuregulin antibody. In
control experiments, the antibody strongly attenuated the up-regulation of NT-3 mRNA by
rhGGF2, but had no effect on NT-3 mRNA up-regulation by PDGF (Figure 7), demonstrating
the specificity of the inhibition. Anti-GGF2/neuregulin also attenuated the up-regulation of
NT-3 mRNA caused by coculture with E14.5 B2+ neuroblasts (Figure 7, compare B2+ neurons
with B2+ neurons plus GGF AB). This indicated that the neuroblast enhancement of NT-3
mRNA production in nonneuronal cells is, at least in part, mediated by neuregulins. The failure
of the antibody to produce a quantitative inhibition of either the neuroblast- or rhGGF2-
mediated effect (Figure 7) suggests that the antibody may not have been saturating, or that not
all neuregulin isoforms are blocked; alternatively, the neuroblasts may produce other NT-3-
inducing signals (e.g., PDGF) not inhibited by the antibody.
Neuroblast-Derived Neuregulins Promote Up-regulation of NT-3-Mediated Bioactivities
Secreted by Nonneuronal Cells
We next sought to determine whether the neuroblast enhancement of NT-3 mRNA expression
in nn cells was accompanied by an increased secretion of NT-3-dependent bioactivities.
Therefore, both TrkA induction and neuroblast survival assays were performed on neuroblasts
cultured in CMs derived from untreated B2− nn cells, or from cocultures of B2− nn cells and
neuroblasts (design illustrated in Figure 4B and 4C). As shown in Figure 5, conditioned
medium from cocultures up-regulated trkA expression in isolated B2+ neuroblasts, whereas
little effect on TrkA expression was observed with CM from nn cells alone (see Figure 5,
compare B2+ neurons with no add). The effect of the coculture CM was attenuated by anti-
NT-3 antibody (see Figure 5, B2+ neurons plus NT-3 AB). This suggests that most or all of
the TrkA-inducing activity in CM derived from cocultures of neuroblasts and nonneuronal
cells is due to NT-3.
CM from cocultures also enhanced neuroblast survival more effectively than did CM from
untreated nn cells (Table 5, CM [untreated B2− cells] versus CM [B2− plus B2+ cells, 10:1];
experiments I and III). In one of three independent experiments, coculture and untreated nn
cell CM enhanced survival to a similar extent (Table 5, experiment II), but the nn cell CM had
a higher level of survival-promoting activity to begin with than it did in the other experiments
(Table 5, row 2). Importantly, all the survival-promoting activity of the coculture CM was
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inhibited by the anti-NT-3 antibody (Table 5, CM [B2− plus B2+] plus anti-NT-3). Taken
together, these data indicate that neuroblasts not only enhance the expression of NT-3 mRNA
in nn cells, but also promote the secretion of NT-3-dependent bioactivities by these cells.
Finally, we asked whether the anti-rhGGF2/neuregulin antibody eliminated the enhanced
secretion of survival-promoting activity by cocultures of neuroblasts and nonneuronal cells.
For this experiment, cocultures of B2− and B2+ cells were allowed to condition their medium
in the presence or absence of anti-rhGGF2 antibody; the survival activity of CM from these
cultures was then compared with that of CM from untreated nn cell cultures (design illustrated
in Figure 4C). In three independent experiments, pretreatment with the anti-GGF/neuregulin
antibody attenuated the survival-promoting activity of the coculture-derived CM (Table 5,
compare CM [B2− plus B2+ plus anti-GGF] with CM [B2− plus B2+ cells, 10:1]). Moreover,
in two of three experiments, the anti-GGF antibody reduced the survival-promoting activity of
the coculture CM to almost exactly that seen with CM from untreated nn cell cultures (Table
5, experiments I and III; compare CM [untreated B2− cells] with CM [B2− plus B2+ plus anti-
GGF]). Control experiments indicated that the antibody effect was overcome by addition of
excess rhGGF2 (Table 5, CM [B2− plus B2+ plus anti-GGF plus GGF]). Additional controls
showed that the anti-GGF2/neuregulin antibody had no effect on neuroblasts grown in basal
medium, or in medium containing insulin (provided to enhance survival by an NT-3-
independent means) (data not shown). Taken together, these data indicated that neuroblast-
derived neuregulin not only promotes NT-3 mRNA synthesis in nn cells, but also increases
secretion of NT-3-dependent neuroblast survival activity from the nn cells.
Discussion
Recent studies have established that developing rat sympathetic neuroblasts undergo a switch
in neurotrophin responsiveness (Birren et al., 1993; DiCicco-Bloom et al., 1993). At E14.5–
E15.5, neuroblasts in both thoraco-lumbar and superior cervical ganglia express TrkC and
respond to NT-3, but do not express TrkA. Beginning at about E16.5, these cells begin to
express TrkA and acquire NGF responsiveness as measured by 24 hr survival assays. Over the
same period of time, TrkC expression by these cells declines, and they become relatively less
sensitive to NT-3 in similar survival assays (Figure 1). Similar switches in neurotrophin
receptor expression have been documented in developing sensory neurons as well (Buchman
and Davies, 1993; Buj-Bello et al., 1994; Davies, 1994). The observation that immature neurons
or neuroblasts are transiently responsive to neurotrophins that differ from their ultimate target-
derived survival factors raises the question of the source and regulation of production of these
interim trophic factors.
Here we show that NT-3 is synthesized by nn cells neighboring sympathetic ganglia, and that
in vitro, these cells can provide sufficient NT-3 to promote survival and TrkA induction in
isolated neuroblasts (Figure 8A, top). In turn, the neuroblasts can enhance NT-3 production in
the nn cells in vitro, via neuregulins and perhaps other factors, such as PDGF (Figure 8A,
bottom). These cell culture experiments thus demonstrate how a reciprocal cell–cell interaction
can coordinate the development of embryonic sympathetic neuroblasts and their neighboring
nonneuronal cells (Figure 8B). The appropriate spatial and temporal expression of NT-3,
neuregulins, and PDGF (Yeh et al., 1991) suggests that this interaction reconstituted in vitro
may reflect normal developmental events that occur in vivo. Bidirectional interactions between
neuroblasts and glia have also been observed in studies of cerebellar development (Hatten,
1987, 1988), although the molecules involved on both sides of the interaction have not been
fully identified. Such reciprocal cell–cell interactions in the developing nervous system may
provide general examples of how the development of tissues containing several distinct but
functionally interrelated cell types is coordinated.
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Ganglionic Nonneuronal Cells Produce Interim Neurotrophins for Embryonic Sympathetic
Neuroblasts
The insertion of a lacZ gene into the NT-3 locus by homologous recombination has allowed
us to visualize the pattern of NT-3 expression in tissues neighboring the developing thoraco-
lumbar sympathetic ganglia. The domain of lacZ-expressing cells excluded the ganglionic
neuroblasts and overlapped that of cells expressing p75, a marker of peripheral glia and their
neural crest precursors (Stemple and Anderson, 1992; Shah et al., 1994). Analysis of
fluorescence-activated cell sorter (FACS)-isolated p75+ cells confirmed that these cells express
NT-3 protein and mRNA. Freshly isolated p75+ cells are glial fibrillary acidic protein–negative
(GFAP−), but can express GFAP when cultured in rhGGF2 plus serum (data not shown). This
suggests that these cells are glial precursors, neural crest cells or both. Because p75+ cells
constitute only 10%–15% of B2− cells, we cannot say that they are the only source of NT-3 in
this cell population. However, RT–PCR measurements indicated that NT-3 transcripts are
enriched at least 10-fold in isolated p75+ cells, compared with levels in B2− cells (after
normalization to actin; data not shown). These observations are consistent with the idea that
p75+ cells are the major if not the only source of NT-3 in the B2− fraction. Taken together,
these data support the idea that at least some of the NT-3-expressing nn cells are glia or their
precursors. However, it is possible that some nonglial mesenchymal cells in the vicinity of
sympathetic ganglia express NT-3 as well and contribute to the local support of neuroblast
survival.
It is well documented that neurotrophins are produced by peripheral targets of sympathetic and
sensory innervation, where they function to support the survival of adequate numbers of
neurons during the period of programmed cell death. The above mentioned data indicate that
neurotrophins are also synthesized by nonneuronal cells located near the cell bodies of
developing sympathetic neuroblasts. This supports our earlier suggestion that NT-3 may
function to provide local, interim trophic support for embryonic sympathetic neuroblasts before
these cells express functional NGF receptors and gain access to target-derived NGF (Birren et
al., 1993). This view is consistent with the idea that most or all cells in the body require trophic
support at multiple stages of development as well as in the adult (Raff, 1992). The acquisition
of NGF dependence would then occur, in part, by a substitution of a target-derived neurotrophin
—NGF—for the interim neurotrophin—NT-3—provided to the neuroblast cell bodies. In
addition, NGF is likely to be provided by glial cells lining the pathway taken by sympathetic
axons to their peripheral targets (Johnson et al., 1988). Such a model does not exclude the
possibility that sympathetic neuroblasts are neurotrophin independent at yet earlier stages of
development; evidence for this has been provided in the chick system (Ernsberger et al.,
1989a). Evidence for a neurotrophin-independent stage in sensory neurogenesis has been
provided as well (Vogel and Davies, 1991).
Regulation of NT-3 Production in nn Cells
NT-3 mRNA expression and the secretion of NT-3-dependent biologic activities in nn cells
can be strongly up-regulated by environmental signals, including GGF2, PDGF, and CNTF.
Earlier data as well as the present results suggest that in vivo, PDGF and GGF/neuregulin may
be produced by sympathetic neurons neighboring the nonneuronal cells. PDGF is well known
to be synthesized by a large number of neurons, including embryonic sympathetic neurons
(Sasahara et al., 1991; Yeh et al., 1991). Previous work has shown that embryonic sympathetic
ganglia contain at least some forms of neuregulin (Marchionni et al., 1993; Meyer and
Birchmeier, 1994). Here we have demonstrated that sympathetic neuroblasts synthesize several
forms of neuregulin, including GGF2, although a quantitative analysis of neuregulin isoforms
in these cells was not undertaken. The fact that CM from B2+ neuroblasts did not induce
NT-3 mRNA, whereas direct contact between these neuroblasts and the nn cells did, suggests
that at least some of the NT-3-inducing activity provided by the neuroblasts may be membrane
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associated. In keeping with this, neuregulins are alternatively spliced to generate several
membrane-associated isoforms, and we observe expression of the cytoplasmic domain–
containing exon (i.e., a transmembrane form) in the neuroblasts by RT–PCR. However, it is
possible that sympathetic neuroblasts also make some secreted forms of neuregulins, which
did not accumulate to sufficient levels in conditioned medium from the low-density cultures,
to influence NT-3 expression in nonneuronal cells.
Sympathetic neuroblasts are not the only neuronal cells that could provide a source of GGF/
neuregulin for NT-3-expressing nn cells in the vicinity of the sympathetic ganglia. The
preganglionic afferent nerves that grow to these ganglia contain the axons of motorneurons,
which have also been shown to express various neuregulin isoforms, including ARIA, an
acetylcholine receptor-inducing activity for skeletal muscle (Falls et al., 1993; Corfas et al.,
1995). These preganglionic fibers pass through the area containing lacZ+ NT-3-expressing
cells and could therefore be an additional source of NT-3-inducing signals. Motor neurons also
contain PDGF mRNA (Sasahara et al., 1991; Yeh et al., 1991). The multiplicity of signals that
can induce NT-3 in vitro makes it difficult to predict which, if any, of these signals will prove
to be essential for NT-3 expression in vivo as determined by single-gene mutational analysis.
Function of NT-3 during Sympathetic Neurogenesis In Vivo
Previously, we demonstrated that NT-3 can exert a dual influence on developing
sympathoblasts in vitro: it can support their survival and in addition can induce the expression
of the NGF receptor TrkA, as a consequence of promoting cell cycle withdrawal (Verdi and
Anderson, 1994). Previous analyses of NT-3−/− mice have provided evidence that NT-3 is
indeed required by at least a subset of sympathetic neurons in vivo, although the precise stage
of development at which this neurotrophin is needed has not yet been determined (Ernfors et
al., 1994; Fariñas et al., 1994). On the other hand, in preliminary experiments we have observed
that TrkA is expressed in the sympathetic ganglia of NT-3−/− mice (I. F., unpublished data).
This may indicate that NT-3 is only one of several functionally redundant factors that can
induce TrkA expression in sympathetic neuroblasts; indeed, we have shown that at least one
other factor, CNTF, induces TrkA expression in vitro as efficiently as NT-3 (Verdi and
Anderson, 1994). Moreover, both CNTF and NT-3 promoted mitotic arrest of sympathetic
neuroblasts, and mitotic inhibitors such as aphidicolin and mitomycin C were also effective
inducers of TrkA (Verdi and Anderson, 1994). These data suggested that the key event
promoting the appearance of TrkA in sympathetic neuroblasts is cell cycle withdrawal. While
NT-3 may accelerate this process in vitro, the timing of mitotic arrest in vivo may be determined
by other environmental signals or by a cell-autonomous mechanism (e.g., see Hart et al.,
1989).
In summary, our results demonstrate that a neurotrophic factor that acts on immature
neuroblasts is produced by nonneuronal cells neighboring these neuroblasts, and that its
production in these cells can in turn be regulated by neuroblast derived signals in vitro. While
the experiments identify some of the signals that are necessary and sufficient to mediate this
interaction in culture, the situation in vivo may be considerably more complex. Nevertheless,
the results illustrate the kind of reciprocal cell–cell interactions that can occur between neuronal
and glial precursors in developing peripheral ganglia. They also shed further light on how
neurotrophins may regulate neuronal survival and differentiation in the period before these
cells gain access to classical target-derived trophic factors.
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Experimental Procedures
Cell Isolation and Culture
Sympathetic neuroblasts and associated ganglionic nonneuronal cells were isolated from E14.5
thoraco-lumbar sympathetic ganglia using MAb B2 for both positive and negative selection,
as previously described (Birren et al., 1993; Verdi and Anderson, 1994). In some experiments,
p75+ cells were isolated by preparative FACS using monoclonal antibody 192 Ig. No neurons
were ever observed in p75-sorted cells; therefore, 100% of the p75+ cells must be contained
within the B2− nonneuronal fraction. RT–PCR determinations indicated that NT-3 transcripts
are enriched at least 10-fold (relative to actin transcripts) in the p75+ fraction compared with
the B2− fraction. Since p75+ cells constitute about 7%–12% of the B2− fraction, this suggests
that most if not all of the NT-3 synthesized by the B2− fraction is synthesized by p75+ cells
within this fraction. However, because of the larger cell numbers obtained, it was more
convenient to work with B2− cells than p75+ cells as a source of immunoisolated nonneuronal
cells.
For assays of TrkA expression and survival in isolated neuroblasts, typically 3,000 cells were
plated per well of a 96-well plate on a poly-D-lysine/laminin substrate, in 100 µl of defined,
serum-free medium (L15–CO2 containing transferrin, selenium, putrescine, progesterone, and
bovine serum albumin). Determinations of neuronal survival were made by manually counting
the number of neurons at 24 and 48 hr and expressing the results as a percentage relative to the
number of cells that attached 2–3 hr after plating. Duplicate or triplicate determinations were
made for each experiment. The results are presented as the mean ± SEM.
In some experiments, neuroblasts and nonneuronal cells were reseparated following coculture
according to the following procedure. Cultures were treated with Hanks’ balanced salt solution
(HBSS; GIBCO) lacking phenol red and Mg2+, in the presence of 1 mM EDTA for 1 min.
Following this incubation, the medium was removed, the plates tapped gently against the hood,
and the dislodged neuroblasts removed in 1 ml of HBSS–EDTA. This procedure removed
>90% of neuroblasts and none of the nonneuronal cells. The neurons were centrifuged and
lysed in RNA extraction buffer, while the nonneuronal cells remaining on the plate were
removed by incubation for 3 min in trypsin–EDTA (GIBCO) prewarmed to 37° C, spun down,
and lysed.
Preparation of nn Cell CM
B2− nn cells (20,000–30,000) were plated with or without growth factors in a volume of 100
µl in wells of 96-well or 48-well plates. CM was removed after 48 hr for TrkA induction
experiments, and after 24 hr for survival experiments. The medium was removed and mixed
with 100 µl of fresh medium. This medium was then used to culture immunoisolated E14.5
sympathetic B2+ neuroblasts for 24 hr. In some experiments, similar numbers of nn cells were
cocultured with a 10-fold lower number of B2+ neuroblasts and conditioned medium taken
from these cocultures after 48 hr.
Neutralizing Antibodies
Turkey anti-NT-3 antibody was a gift from Amgen, Incorporated and has been previously
demonstrated not to cross-react with other neurotrophins (Ghosh et al., 1994; Ghosh and
Greenberg, 1995). This antibody was used at a final concentration of 580 ng/ml, which was
10-fold higher than the amount needed to block the survival-promoting activity of 40 ng/ml
NT-3. In the experiment of Figure 3, a polyclonal rabbit anti-NT-3 antibody (the gift of D.
Kaplan) was used for immunostaining at a dilution of 1:1000. This antibody is monospecific
for NT-3 in Western blots (D. Kaplan, personal communication). Anti-GGF was a cocktail of
two antibodies: CN16, an affinity-purified polyclonal antiserum raised against intact rhGGF2
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and used at a final concentration of 20 µg/ml; and 2861, an affinity-purified polyclonal antibody
raised against an exon I–specific peptide, used at 12 µg/ml. This amount of antibody was
sufficient to block completely the activity of 10–20 ng/ml rhGGF2 in a Schwann cell DNA
synthesis assay. A detailed characterization of these antibodies will be reported elsewhere (N.
Ratner et al., submitted). Anti-GGF antibody was added to cocultures of neuroblasts plus nn
cells and was preincubated with the neuroblasts prior to plating to facilitate binding to cell
surface–associated forms of GGF/neuregulin.
RT–PCR
Conditions for RNA extraction, cDNA synthesis, and RT–PCR for trkA and actin were as
described previously (Verdi and Anderson, 1994). RT–PCR for NT-3 was performed with the
following primers and amplification conditions. Forward primer, AGG TGA TGT CCA TCT
TGT TTT; reverse primer, GCC TCT CCC TGC TCT GGT TC. Conditions employed a hot
start, 1 min at 97°C, 1 min at 52°C, 1 min at 72°C for 35 cycles. For all quantitative
measurements, input cDNA levels were normalized with actin primers (Verdi and Anderson,
1994). RT–PCR for various isoforms of GGF/neuregulin was performed under the conditions
described previously (Shah et al., 1994). Exact primer sequences used are available on request.
Growth Factors
Recombinant NT-3 and CNTF were obtained from Amgen, Incorporated and Regeneron,
Incorporated, respectively, and were used at final concentrations of 25 and 2 ng/ml,
respectively. rhGGF2 was obtained from Cambridge NeuroScience, Incorporated and was used
at concentrations that gave maximal activity in a Schwann cell DNA synthesis assay (typically
10 nM). Recombinant PDGF was from Sigma and was used at a final concentration of 20 ng/
ml.
Analysis of NT-3−/− Mice
Mice containing the lacZ gene inserted into the NT-3 locus by homologous recombination have
been described previously (Fariñas et al., 1994). Embryos were genotyped by DNA blot
analysis and processed by cryostat sectioning for detection of β-galactosidase activity with the
X-Gal reagent, followed by immunostaining for peripherin (antibody from Sigma,
Incorporated) or p75 (antibody Rex; Weskamp and Reichardt, 1991).
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Figure 1.
Schematics Showing the Switch in Neurotrophin Responsiveness by Embryonic Rat
Sympathetic Neuroblasts, and the Regulatory Circuits Underlying the Switch
(A) The switch in neurotrophin responsiveness by embryonic rat sympathetic neuroblasts
(Birren et al., 1993; DiCicco-Bloom et al., 1993).
(B) The regulatory circuits underlying the switch.
The induction of TrkA expression in neuroblasts exposed to NT-3 or CNTF appears to be
primarily a consequence of mitotic arrest (Verdi and Anderson, 1994). In vitro, exposure of
TrkA-expressing neuroblasts to NGF results in both an induction of p75 expression (Wyatt
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and Davies, 1993; Verdi and Anderson, 1994) and a down-regulation of TrkC expression
(Verdi et al., 1994b).
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Figure 2.
Expression of NT-3 in Sympathetic Ganglionic Nonneuronal Cells In Vivo
Transverse sections through the thoracic region of E13.5 mouse embryos containing two copies
of the lacZ gene inserted into the NT-3 locus by homologous recombination. In (A), the sections
are counterstained with antibody to peripherin; arrows indicate the sympathetic ganglia. In (B),
the sections are counterstained with antibody to p75, which reveals nonneuronal cells adjacent
to the sympathetic ganglion. Ao, dorsal aorta; sg, sympathetic ganglion.
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Figure 3.
Expression of NT-3 in Isolated p75+ Ganglionic Nonneuronal Cells
Rat E14.5 thoracic sympathetic ganglia were dissociated and sorted by use of anti-p75
monoclonal antibody. The isolated p75+ cells were plated overnight, fixed, and stained with
rabbit anti-NT-3 antibody (see Experimental Procedures) at a 1:1000 dilution (A and B) or
preimmune serum at the same dilution as a control (C and D). (A) and (C) are phase contrast
micrographs of the bright-field images in (B) and (D), respectively.
Verdi et al. Page 18
Neuron. Author manuscript; available in PMC 2009 July 16.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 4.
Schematic Diagram Illustrating Design of Conditioned Medium Experiments
Survival or TrkA expression by isolated B2+ neuroblasts is measured after culture in the
presence of specific growth factors (A), or in conditioned media (CM) derived from B2–
nonneuronal cells cultured either alone (B) or in the presence of neuroblasts (C). The CMs are
prepared in the presence or absence of various growth factors, or in the presence or absence of
blocking antibodies to GGF/neuregulin (C). The CMs are applied to the isolated neuroblasts
in the presence or absence of blocking antibodies to NT-3. The survival or expression of TrkA
is measured in the isolated neuroblast preparations.
Verdi et al. Page 19
Neuron. Author manuscript; available in PMC 2009 July 16.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 5.
Conditioned Medium from B2− Nonneuronal Cell Cultures Induces TrkA Expression in
Cultures of Isolated Sympathetic Neuroblasts, via NT-3
The left of the graph (factor added directly) shows a series of controls in which factors or
antibodies were added directly to isolated B2+ neuroblasts. Note that NT-3 induces trkA
mRNA, and that the neutralizing anti-NT-3 antibody blocks this effect. In the right of the graph,
expression of TrkA was monitored in cultures of isolated B2+ neuroblasts grown for 24 hr in
various conditioned media from nonneuronal cultures. No add means that the conditioned
medium was prepared from nn cultures grown with no added factors. Note that GGF strongly
enhances the TrkA-inducing activity of nn cell CM, although by itself, GGF has no direct effect
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on TrkA expression in isolated neuroblasts (left side of the graph). The TrkA-inducing activity
of the GGF-treated CM is strongly attenuated by anti-NT-3 antibody. A similar result is
obtained with PDGF. The effect of CNTF is, as expected, not blocked by anti-NT-3, because
CNTF itself has strong TrkA-inducing activity (Verdi and Anderson, 1994). B2+ neurons
indicates that conditioned medium was prepared from a coculture of B2− nonneuronal cells
and B2+ neurons recombined in a 10:1 ratio (see Figure 4C). Note that this CM has much higher
TrkA-inducing activity than control CM (no add) and that this activity is again attenuated by
the blocking anti-NT-3 antibody. The relative levels of trkA mRNA were determined by RT–
PCR and are presented as the percentage of trkA mRNA detected in PC12 cell mRNA samples
run in parallel; the numbers are the mean ± SEM of replicate samples. Similar results were
obtained in two different experiments from separate isolations.
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Figure 6.
Relative Levels of GGF2/Neuregulin in Freshly Isolated B2+ Sympathetic Neuroblasts
cDNA prepared from cells isolated at the indicated ages was amplified with exon 1–specific
primers that detect the kringle domain of the GGF2 isoform (see Table 3). The values represent
the mean ± SEM of two independent experiments, relative to the level detected at E17.5 after
normalization to actin. Levels of GGF2 mRNA at E19.5 were below the detection limit of the
assay. Note that GGF2 mRNA was not detectable in samples of B2− nonneuronal cell cDNA
run in parallel. Qualitative results obtained with other neuregulin primer sets are presented in
Table 3.
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Figure 7.
Induction of NT-3 mRNA in Nonneuronal Cells by Coculture with Neuroblasts Is Attenuated
by Neutralizing Anti-GGF Antibody
Relative NT-3 mRNA levels in cultures of B2− nonneuronal cells grown under different
conditions for 24 hr were determined by RT–PCR (see Table 1) and normalized to actin mRNA
levels. rhGGF2 strongly up-regulates NT-3 (see also Table 1), and this effect is attenuated by
anti-GGF antibody. By contrast, the up-regulation of NT-3 obtained with PDGF is unaffected
by the anti-GGF antibody. NT-3 mRNA levels are also up-regulated by coculture with B2+
neuroblasts, and this effect is also attenuated by the anti-GGF antibody. The data represent the
average ± SEM of two independent experiments.
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Figure 8.
Summary of Experimental Observations and Model for Reciprocal Cell–Cell Interactions
Controlling Early Stages in Sympathetic Gangliogenesis
(A, top) Illustration of the data indicating first of all that NT-3 promotes neuroblast survival
and mitotic arrest/TrkA expression (see also Verdi and Anderson, 1994); second, that B2−
ganglionic nonneuronal cells also promote neuroblast survival and TrkA expression (and
express NT-3); and third, that blocking anti-NT-3 antibodies inhibit the survival-promoting
and TrkA-inducing activities in conditioned medium from nonneuronal cells.
(A, bottom) Illustration of the data indicating first of all that GGF and PDGF (as well as CNTF)
up-regulate NT-3 expression in nonneuronal cells; second, that neuroblasts also up-regulate
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NT-3 expression in non-neuronal cells (and themselves express forms of GGF/neuregulin as
well as PDGF [Yeh et al., 1991]); and third, that blocking anti-GGF antibodies inhibit the
ability of neuroblasts to up-regulate NT-3 expression in nonneuronal cells.
(B) Reciprocal cell–cell interactions that occur in vitro between neuroblasts and nonneuronal
cells as suggested by the data.
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Table 1
Relative Levels of NT-3 mRNA in Cultures of B2− Ganglionic Nonneuronal Cells Treated with Various Factors
Factor 24 hr 48 hr
Control 1.0 ± 0.0 1.4 ± 0.3
IGF-1 1.2 ± 0.3 0.8 ± 0.2
NGF 1.5 ± 0.3 1.9 ± 0.2
CNTF 5.2 ± 0.4 47 ± 2.4
rhGGF2 6.4 ± 1.2 43 ± 3.8
PDGF 4.8 ± 1.6 12 ± 1.8
B2+ neuroblasts 7.1 ± 0.8 13 ± 1.4
Presented is the mean ± SEM from two experiments derived from independent cell isolations. Values represent the levels of NT-3 mRNA as assayed by
a quantitative RT–PCR procedure. The values are normalized to the 24 hr control determinations for easier comparison; however, the control cultures
contained easily detectable amounts of NT-3 mRNA.
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Table 2
Neuroblast Survival at 48 hr Promoted by Growth Factors and nn Cell–Conditioned Media
Condition
Percentage of Neurons Recovered
Experiment I Experiment II Experiment III
No addition 22 ± 4.4 25 ± 1.4 15 ± 3.5
Anti-NT-3 25 ± 1.8 ND ND
NT-3 66 ± 7.0 80 ± 4.2 75 ± 6.2
Anti-NT-3 plus insulin 70 ± 2.7 ND ND
rhGGF2 24 ± 1.9 28 ± 1.9 14 ± 0.9
PDGF ND 27 ± 0.9 12 ± 1.3
CNTF ND 25 ± 1.1 16 ± 6
CM (untreated B2− cells) 47 ± 0.6 69 ± 4.7 31 ± 4.2
CM (B2− cells) plus anti-NT-3a 22 ± 2.1 25 ± 4.6 13 ± 3.2
CM (B2− cells plus GGF) 67 ± 4.4 78 ± 1.6 59 ± 3.2
CM (B2− cells plus GGF) plus anti-
NT-3a
19 ± 2.4 24 ± 3.9 10 ± 5.2
CM (B2− cells plus CNTF) 66 ± 3.2 70 ± 2.4 49 ± 1.6
CM (B2− cells plus PDGF) ND 69 ± 3.3 43 ± 1.8
The percentage of surviving neuroblasts at 48 hr is indicated. Numbers represent the mean ± SEM of triplicate determinations of 100–200 cells/well, for
each of three independent experiments. B2+ neuroblast survival was assayed in presence of purified factors (top), or in conditioned medium (CM) from
B2− nonneuronal cells (bottom). Bottom, conditions in brackets indicate factors present during preculture to produce CM. The conditions shown at the
bottom were tested in parallel with those at the top for each of three independent experiments; therefore the values at the bottom for each individual
experiment should be compared with the control values (no addition) at the top for the corresponding experiment. ND, not done.
a
Anti-NT-3 was added at the time of assay of the CM on the isolated neuroblast cultures. Anti-NT-3 also blocked the activity of CM from PDGF- and
CNTF-treated B2− cells (data not shown). This table shows first of all that CM enhances the survival of neuroblasts; second, that anti-NT-3 blocks the
effect of CM; and third, that GGF, CNTF, and PDGF increase this activity of CM but have no direct effect on neuroblasts on their own.
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Table 3
Expression of Neuregulin Isoforms by Isolated E14.5 B2+ Sympathetic Neuroblasts
Primer Set Exon Pairs Expression Detected
5′ kringle–3′ kringle 1–1 ++
5′ Ig–3′ EGF 4–6 +
5′ Ig–3′ Cyt 4–11 −
5′ Ig–3′ Sec 4–10 −
5′ kringle–3′ Sec 1–10 +/−
5′ EGF–3′ Cyt 6–11 +++
5′ EGF–3′ Sec 6–10 −
RT–PCR was performed on cDNA prepared from E14.5 B2+ neuroblasts, using the indicated primer pairs. The results of the amplification were visualized
by agarose gel electrophoresis with ethidium bromide staining. Band intensities are approximated by plus and minus symbols. The strongest signal was
obtained for a membrane-bound form containing the EGF-like domain (5′ EGF-3′ Cyt). Locations and orientations of the primers used are indicated in
the diagram; 5′ primers point rightwards, 3′ primers leftwards. Exon numbers are indicated below the boxes in the diagram, and domains are overlined.
Neuregulin domain abbreviations: kringle, exon 1 (specific to rhGGF2); Ig, immunoglobulin-like domain, exon 4; EGF, EGF repeat domain, exon 6; Cyt,
cytoplasmic domain, exon 11 (transmembrane form); Sec, putative secreted form with stop codon before transmembrane segment, exon 10.
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Table 4
Survival of Serially Observed Cohorts of B2+ Cells in Coculture with B2− Nonneural Cells under Various Conditions
Condition
Percentage of Neurons Surviving
24 hr 48 hr
Control 77 ± 4.9 63 ± 9.2
rhGGF2 82 ± 3.8 78 ± 1.6
Anti-GGF 59 ± 7.4 51 ± 11.2
Anti-NT-3 52 ± 8.2 30 ± 2.4
Anti-GGF plus rhGGF2 79 ± 3.8 73 ± 1.4
Anti-GGF plus insulin 93 ± 0.7 86 ± 0.8
Anti-NT-3 plus insulin 81 ± 13.5 88 ± 2.8
For each of the above conditions, 100–150 neuroblasts were identified in each of three plates (for a total of 300–450 neurons per condition), at 2 hr after
plating. The survival of these identified cells was monitored at 24 hr and at 48 hr. The percent survival relative to 2 hr after plating was calculated for
each plate; the mean ± SEM of these percentages is indicated in the table. At 48 hr, the data are from duplicate rather than triplicate plates.
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Table 5
Neuroblast Enhancement of Secretion of NT-3-Mediated Neurotrophic Activity from Nonneuronal Cells Is Dependent
upon Endogenous Neuregulins
Condition
Percentage of Neurons Recovered
Experiment I (%) Experiment II (%) Experiment III (%)
No addition 22 ± 4.4 25 ± 1.4 15 ± 3.5
CM (untreated B2− cells) 47 ± 0.6 (113.6) 69 ± 4.7 (176) 31 ± 4.2 (138)
CM (B2− plus B2+ cells,
10:1)
56 ± 0.2 (154) 70 ± 2.8 (180) 44 ± 4.2 (193)
CM (B2− plus B2+) plus
anti-NT-3
21 ± 1.8 (0) 25 ± 3.7 (0) 13 ± 1.9 (0)
CM (B2− plus B2+ plus
anti-GGF)
47 ± 2.2 (113.6) 36 ± 4.5 (44) 35 ± 3.5 (133)
CM (B2− plus B2+ plus
anti-GGF plus GGF)
72 ± 2.5 (188) 56 ± 2.8 (273)
The percentage of surviving neuroblasts at 48 hr is indicated. B2+ neuroblast survival was assayed in control medium (no addition), or in conditioned
medium (CM) from B2− nonneuronal cells precultured alone (untreated B2− cells) or together with B2+ neuroblasts in a 10:1 ratio (B2− /B2+). The data
in the first two rows are taken from Table 2. Row 4, anti-NT-3 was added at the time of assay of the CM on the isolated neuroblast cultures. Rows 5 and
6, anti-GGF indicates that anti-GGF2 antibody was added to the cocultures at the time of plating (see Figure 4C). Numbers in parentheses indicate the
percent increase over control (no addition) observed in each CM condition. This is calculated as ([% survival in CM – % survival in no addition] ÷ %
survival in No Addition) × 100. All percent increases were statistically significant (p ≥.034) as determined by a 2-tailed Student’s t test. Note that while
CM from cultures of B2− cells alone enhances survival (by 113.6%–176%), CM from cocultures of B2− and B2+ cells is more efficacious (by 154%–
193%) (except in Experiment II, in which a higher basal level of survival activity in B2− CM was obtained). This greater efficacy is eliminated by inclusion
of anti-GGF antibody during the preparation of CM, and the antibody effect is reversed by inclusion of excess recombinant human GGF. Anti-GGF
antibody had no effect on CM from nonneuronal cells grown in the absence of neuroblasts (data not shown).
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